Living With An Insulin Pump

Of the 200 million people worldwide who have been diagnosed with diabetes, millions receive their diabetes care through insulin pump therapy and use continuous glucose monitors (CGMs) and insulin pumps.[1] This may result in improved diabetes care and greater control over users’ blood glucose levels. “My overall health is better. Insulin delivery is better, so…

Details

Mastisol® Liquid Adhesive: Evidence‐Based Decision Making for the Prevention of Catheter‐Related Blood Stream Infections

The public health burden associated with catheter‐related bloodstream infection (CRBSI*) is substantial. A publication reviewing the qualitative and quantitative evidence supporting the use of Mastisol® Liquid Adhesive for the reduction of CRBSI can be downloaded here. In this blog, we’ll review the important findings detailed in this publication.       CRBSI vs CLABSI These two…

Details

Addressing the Dressing: Improving Vascular Access Dressing Disruption

The US Centers for Disease Control and Prevention (CDC) and The Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing integrity is a critical factor for the prevention of hospital acquired infection. Michelle DeVries, BS, MPH, CIC, VA-BC, Senior Infection Control Officer at Methodist Hospitals, Indiana, reviews current practice guidelines, the emerging literature, and her…

Details

LVADs: Minimizing Driveline Infections at Home

The previous blog of this 2‐part series focused on Left Ventricular Assist Devices (LVADs), including the prevalence of use, the types of patients treated, and the associated risks of LVAD‐associated infections. (View Blog 1 of 2) Part 2 of the series will focus on minimizing driveline infections once the patient goes home. LVADs have revolutionized…

Details

CHF, LVADs, and Reducing Infection Risk

Welcome to the first of a 2-part series on Left Ventricular Assist Devices (LVADs). Part 1 will provide an overview of LVADs, types of patients treated and the associated risks. Congestive Heart Failure (CHF) is a leading cause of death worldwide. CHF is estimated to impact over 20 million people in the world, 2.2 million…

Details